Tri-GalNAc Ligand LCAA CPG 500A
Tri-GalNAc Ligand LCAA CPG 500A
製品概要
クイックビュー
- 製品ファミリー
- Oligonucleotide Conjugation & Delivery Ligands
- 化学名
- Tri-GalNAc Ligand LCAA CPG 500A
Tri-GalNAc Ligand LCAA CPG 500A is listed by CHEMOS as catalog CH52019.
The catalog record does not include CAS, formula, MW, support loading, support certificate, chemical name, or PubChem CID; no direct PubMed record is cited for the exact product name.
Controlled-pore-glass and triple-GalNAc CPG supports are reported in oligonucleotide synthesis contexts, but those references do not verify CH52019 pore size, loading, support chemistry, or performance.
同定情報と仕様
| Catalog No. | CH52019 |
| Product Name | Tri-GalNAc Ligand LCAA CPG 500A |
| CAS No. | Not assigned |
| Formula / MW | Use support specifications after confirmation |
| Support Loading | Not listed |
| Pore Size | Not listed |
| Public CID | No public CID cited |
用途情報
- GalNAc CPG solid-support class context
- Solid-phase oligonucleotide synthesis published studies
補足材料情報
用途
This catalog entry is limited to support identity information. Loading, category, and product-specific specifications are not included.
特性
The catalog name suggests a tri-GalNAc ligand on LCAA CPG support. Support type, 500A pore-size evidence, loading, LCAA derivatization, and ligand identity are not included in the catalog record.
関連技術資料
公開情報源
- Targeted delivery of antisense oligonucleotides to hepatocytes using triantennary N-acetyl galactosamine improves potency in mice
Nucleic Acids Research, 2014
Product-family technical context
- Multivalent N-acetylgalactosamine-conjugated siRNA localizes in hepatocytes and elicits RNAi-mediated gene silencing
Journal of the American Chemical Society, 2014
Product-family technical context
- siRNA Conjugates Carrying Sequentially Assembled Trivalent N-Acetylgalactosamine Linked Through Nucleosides Elicit Robust Gene Silencing In Vivo in Hepatocytes
ACS Chemical Biology, 2015
Product-family technical context
- Comparative Characterization of Hepatic Distribution and mRNA Reduction of Antisense Oligonucleotides Conjugated with Triantennary N-Acetyl Galactosamine and Lipophilic Ligands
Journal of Pharmacology and Experimental Therapeutics, 2016
Product-family technical context
よくある質問
What is listed for CH52019?
CH52019 is listed as Tri-GalNAc Ligand LCAA CPG 500A.
Is the 500A pore size verified?
available data treat pore size as Not listed because no support certificate or specification evidence was available.
Why is molecular weight omitted?
This record is a functionalized CPG support candidate, so loading and support specifications are more relevant than a small-molecule MW and remain Not listed.
類似製品
材料選択の支援が必要ですか？
CHEMOSは製品適合性、目標構造、ルート上の課題、分析要件、プロジェクト別供給ニーズを確認します。